Prabhjeet B. Singh

Pilani, RJ 333031, India

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Predicting targeted- and immunotherapeutic response outcomes in melanoma with single-cell Raman spectroscopy and AI.

Predicting targeted- and immunotherapeutic response outcomes in melanoma with single-cell Raman spectroscopy and AI.

Journal: bioRxiv : the preprint server for biology
Published: March 27, 2026

Rapamycin loaded lipid-polymer hybrid nanoparticles in a topical hydrogel for the treatment of psoriasis.

Rapamycin loaded lipid-polymer hybrid nanoparticles in a topical hydrogel for the treatment of psoriasis.

Journal: Journal of pharmaceutical sciences
Published: November 04, 2025

cRGD-Functionalized Nanohybrid Conjugates Codelivering Temozolomide and Rapamycin for Treating Glioblastoma Multiforme: In Vitro and In Vivo Evaluation.

cRGD-Functionalized Nanohybrid Conjugates Codelivering Temozolomide and Rapamycin for Treating Glioblastoma Multiforme: In Vitro and In Vivo Evaluation.

Journal: Molecular pharmaceutics
Published: October 23, 2025

Antibody-Free Immunopeptide Nanoconjugates for Brain-Targeted Drug Delivery in Glioblastoma Multiforme.

Antibody-Free Immunopeptide Nanoconjugates for Brain-Targeted Drug Delivery in Glioblastoma Multiforme.

Journal: Bioconjugate chemistry
Published: July 02, 2025

Antibody-Free Immunopeptide Nano-Conjugates for Brain-Targeted Drug Delivery in Glioblastoma Multiforme.

Antibody-Free Immunopeptide Nano-Conjugates for Brain-Targeted Drug Delivery in Glioblastoma Multiforme.

Journal: bioRxiv : the preprint server for biology
Published: March 31, 2025

Enhancing temozolomide in vivo stability and efficacy through hybrid nanoconjugate approach for improved glioblastoma multiforme treatment.

Enhancing temozolomide in vivo stability and efficacy through hybrid nanoconjugate approach for improved glioblastoma multiforme treatment.

Journal: Asian journal of pharmaceutical sciences
Published: November 13, 2023

Self-Assembled Lecithin-Chitosan Nanoparticles Improved Rotigotine Nose-to-Brain Delivery and Brain Targeting Efficiency.

Self-Assembled Lecithin-Chitosan Nanoparticles Improved Rotigotine Nose-to-Brain Delivery and Brain Targeting Efficiency.

Journal: Pharmaceutics
Published: December 11, 2022

Temozolomide-fatty acid conjugates for glioblastoma multiforme: In vitro and in vivo evaluation.

Temozolomide-fatty acid conjugates for glioblastoma multiforme: In vitro and in vivo evaluation.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 28, 2022

Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme.

Polymeric and small molecule-conjugates of temozolomide as improved therapeutic agents for glioblastoma multiforme.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: March 25, 2022

Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment.

Folate targeted hybrid lipo-polymeric nanoplexes containing docetaxel and miRNA-34a for breast cancer treatment.

Journal: Materials science & engineering. C, Materials for biological applications
Published: March 18, 2021

RNA Interference Nanotherapeutics for Treatment of Glioblastoma Multiforme.

RNA Interference Nanotherapeutics for Treatment of Glioblastoma Multiforme.

Journal: Molecular pharmaceutics
Published: September 09, 2020

Metformin: Is It the Well Wisher of Bone Beyond Glycemic Control in Diabetes Mellitus?

Metformin: Is It the Well Wisher of Bone Beyond Glycemic Control in Diabetes Mellitus?

Journal: Calcified tissue international
Published: September 07, 2020
Showing 1-12 of 16

Last Updated: 09/26/2026